Cholesterol and membrane lipids

Cholesterol and membrane lipids are fundamental structural elements of the cellular lipid bilayer, essential for maintaining membrane integrity, fluidity, and permeability (Alberts B, et al., Molecular Biology of the Cell). These molecules are not merely passive barriers but are actively involved in organizing lipid rafts—specialized microdomains that facilitate signal transduction and protein sorting (Simons K, et al., Nature, 1997). Dysregulation of lipid homeostasis is central to numerous pathologies, including cardiovascular diseases like atherosclerosis and rare genetic disorders such as Niemann-Pick disease type C, where cholesterol accumulates pathologically in lysosomes (Vance JE, et al., Journal of Lipid Research, 2014). In pharmacology, these lipids serve as direct targets for various therapeutic agents; for example, polyene antifungals like Amphotericin B bind to membrane sterols to form trans-membrane pores that cause lethal ion leakage (Baginski M, et al., Current Drug Targets, 2009). Furthermore, synthetic agents like cyclodextrins are employed to sequester and remove excess cholesterol from cells, while certain lipopeptide antibiotics target specific bacterial membrane lipids to disrupt cell wall stability (Matsuzaki K, Biochimica et Biophysica Acta, 2009). While 'Cholesterol and membrane lipids' represents a broad category of molecules rather than a single protein target, their collective role in membrane architecture makes them a critical focus for drug development and disease management.

Other names

Membrane sterolsCellular lipidsLipid bilayer componentsPlasma membrane lipids

Drugs targeting membrane lipids primarily function through physical-chemical disruption or sequestration. Polyene antifungals (e.g., Amphotericin B) bind to membrane sterols—preferentially ergosterol in fungi but also cholesterol in humans—to form aqueous pores that lead to the leakage of essential intracellular ions and cell death (Baginski M, et al., Curr Drug Targets, 2009). Cyclodextrins act as molecular chelators that encapsulate cholesterol within their hydrophobic cavities, facilitating its removal from overloaded cells in conditions like Niemann-Pick disease type C (Vance JE, et al., J Lipid Res, 2014). Other agents, such as polymyxins and lipopeptides, target specific anionic lipids or lipopolysaccharides in bacterial membranes, causing membrane depolarization and loss of structural integrity (Matsuzaki K, Biochim Biophys Acta, 2009).